A Special Extract of Bacopa monnieri (CDRI-08)-Restored Memory in CoCl2-Hypoxia Mimetic Mice Is Associated with Upregulation of Fmr-1 Gene Expression in Hippocampus.
Study Design
- Loại nghiên cứu
- Other
- Đối tượng nghiên cứu
- men
- Can thiệp
- A Special Extract of Bacopa monnieri (CDRI-08)-Restored Memory in CoCl2-Hypoxia Mimetic Mice Is Associated with Upregulation of Fmr-1 Gene Expression in Hippocampus. 1 g
- Đối chứng
- None
- Kết quả chính
- None
- Xu hướng hiệu quả
- Mixed
- Nguy cơ sai lệch
- Unclear
Abstract
Fragile X mental retardation protein (FMRP) is a neuronal translational repressor and has been implicated in learning, memory, and cognition. However, the role of Bacopa monnieri extract (CDRI-08) in enhancing cognitive abilities in hypoxia-induced memory impairment via Fmr-1 gene expression is not known. Here, we have studied effects of CDRI-08 on the expression of Fmr-1 gene in the hippocampus of well validated cobalt chloride (CoCl2)-induced hypoxia mimetic mice and analyzed the data with alterations in spatial memory. Results obtained from Morris water maze test suggest that CoCl2 treatment causes severe loss of spatial memory and CDRI-08 is capable of reversing it towards that in the normal control mice. Our semiquantitative RT-PCR, Western blot, and immunofluorescence microscopic data reveal that CoCl2-induced hypoxia significantly upregulates the expression of Hif-1α and downregulates the Fmr-1 expression in the hippocampus, respectively. Further, CDRI-08 administration reverses the memory loss and this is correlated with significant downregulation of Hif-1α and upregulation of Fmr-1 expression. Our data are novel and may provide mechanisms of hypoxia-induced impairments in the spatial memory and action of CDRI-08 in the recovery of hypoxia led memory impairment involving Fmr-1 gene encoded protein called FMRP.
Tóm lược
Effects of CDRI-08 on the expression of Fmr-1 gene in the hippocampus of well validated cobalt chloride (CoCl2)-induced hypoxia mimetic mice are studied and data with alterations in spatial memory are analyzed to provide mechanisms of Hypoxia-induced impairments in the spatial memory.
Full Text
Research Article
A Special Extract of Bacopa monnieri (CDRI-08)-Restored
Memory in CoCl2-Hypoxia Mimetic Mice Is Associated with Upregulation of Fmr-1 Gene Expression in Hippocampus
Anupama Rani and S. Prasad
Biochemistry & Molecular Biology Lab, Centre of Advanced Study in Zoology, Banaras Hindu University, Uttar Pradesh, Varanasi 221005, India
Correspondence should be addressed to S. Prasad; [email protected] Received 29 September 2014; Accepted 1 April 2015 Academic Editor: Con Stough
Copyright © 2015 A. Rani and S. Prasad. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
FragileXmentalretardationprotein(FMRP)isaneuronaltranslationalrepressorandhasbeenimplicatedinlearning,memory,and cognition. However, the role of Bacopa monnieri extract (CDRI-08) in enhancing cognitive abilities in hypoxia-induced memory impairment via Fmr-1 gene expression is not known. Here, we have studied effects of CDRI-08 on the expression of Fmr-1 gene in the hippocampus of well validated cobalt chloride (CoCl2)-induced hypoxia mimetic mice and analyzed the data with alterations in spatial memory. Results obtained from Morris water maze test suggest that CoCl2 treatment causes severe loss of spatial memory and CDRI-08 is capable of reversing it towards that in the normal control mice. Our semiquantitative RT-PCR, Western blot, and immunofluorescence microscopic data reveal that CoCl2-induced hypoxia significantly upregulates the expression of Hif-1𝛼 and downregulates the Fmr-1 expression in the hippocampus, respectively. Further, CDRI-08 administration reverses the memory loss and this is correlated with significant downregulation of Hif-1𝛼 and upregulation of Fmr-1 expression. Our data are novel and may provide mechanisms of hypoxia-induced impairments in the spatial memory and action of CDRI-08 in the recovery of hypoxia led memory impairment involving Fmr-1 gene encoded protein called FMRP.
1. Introduction
Brain requires a continuous supply of oxygen to perform its normal function. Being the largest consumer of oxygen, it is especially sensitive to hypoxia, a condition in which brain receives reduced oxygen. Several studies have shown that injury to the brain due to loss of oxygen triggers memory loss and causes learning and memory deficits [1, 2]. Although the whole brain is susceptible to hypoxia, hippocampus in particular has been reported to be severely affected by hypoxia [3, 4] as it plays crucial roles in encoding and consolidating memory [5, 6].
Memory formation, maintenance, and retrieval are dynamic processes involving transcription, translation, and expression of several proteins [7]. Fragile X mental retardation protein (FMRP), an mRNA-binding protein [8–11], is prevalently present in dendritic spines [12] and regulates protein synthesis relevant to synaptic plasticity [10]. FMRP
was first characterized in context of the fragile X syndrome (FXS) which results from loss of function mutations in Fmr1 gene, which in turn results in mental retardation, loss of memory,andabnormalcognitivebehaviorinfragileXmental retardation syndromes (FXS). FMRP is a 70–80KDa protein abundantly expressed in brain and testis [13, 14]. FMRPmediated translational regulation plays important roles in proper synaptic connectivity [15] and plasticity [16, 17]. Since the dendritic protein synthesis required for achieving synaptic plasticity is under the strict control [18, 19], any change in the level of FMRP may lead to alterations in the synaptic plasticity, thus learning and memory. Whether hypoxia leads to any alterations in the expression of Fmr-1 gene is not known. Therefore, we have examined the effects of hypoxia on the expression of the Fmr-1 gene at transcript and protein levels in relation to learning and memory in cobalt chloride-induced hypoxia mimetic mouse model.
Bacopa monnieri, also known as Brahmi, is a traditional Ayurvedic medicinal plant and it has been extensively used in India as a nerve tonic for centuries [20]. In the Indian Ayurvedic system of medicine, Bacopa monnieri belongs to a groupof medicine called “Medhya Rasayana”which is known to act on nervous system and improve mental abilities by enhancing memory and tunes cognition. Bacopa monnieri extract contains mixture of saponins, for example, bacoside A,bacopasidesIandII,bacopasaponinC,andflavonoids[21– 23], as active constituents. Its extract has been reported to facilitate cognitive functions as well as to augment mental retention capacity. There is evidence that the mechanism of action of Bacopa monnieri could be attributed to a combination of cholinergic modulation [24–27] and antioxidant effects [28–31]. Although many reports suggests the nootropic capabilities of Bacopa monnieri extract, its effect on Fmr-1 gene expression in relation to learning and memory has not been studied to date. In the light of the crucial role playedbytheFmr-1geneencodedFMRPintheformationand maintenance of synaptic connectivity, it is possible that Fmr-1 gene could be one of the targets of bacoside’s action during memory enhancement. Therefore, in the present study, we have investigated whether hypoxic condition leads to any alteration in spatial memory and this alteration is associated with change in the expression of FMRP in the hippocampus of cobalt chloride-induced hypoxic mouse model [32], and further we studied whether a selected dose of CDRI-08 (obtained from a pilot study) recovers the alteration in spatial memoryandreversesalterationsinthe Fmr-1geneexpression in the hippocampus due to hypoxia.
2. Materials and Methods
- 2.1. Materials. A standardized extract of Bacopa monnieri (CDRI-08) containing 58.18% of bacosides was received as a kind gift from Dr. H. K. Singh, Director, Lumen Research Foundation, Chennai, India. Cobalt chloride was purchased from Sisco research laboratory, India (SRL). All other chemicalsandreagentswereofanalyticalgradeandpurchasedfrom Merck, India, and Sigma Aldrich, USA.
- 2.2. Animals and Drug Treatment. Male Swiss albino mice of age 20 ± 5 weeks, weighing 25 ± 5g were used in the present study. Mice were housed in the animal house maintained at 25 ± 2∘C with alternating 12h light and dark cycles, access to standard mice feed and water ad libitum. All experimental procedures were approved by the ethical committee of Banaras Hindu University. Prior to exposure to hypoxiamimeticconditionmiceweretrainedinMorriswater maze for 8 days. After training, mice were randomly divided intosixgroups(𝑛 = 7micepergroup)fordifferenttreatments as (1) control group (C) administered with 5% Tween 80, (2) BrahmigrouporallytreatedwithstandardizeddoseofBacopa monnieri extract (CDRI-08) (200mg/KgBW) dissolved in 5% Tween-80 for 8 days, (3) hypoxia group 1 (HA) in which mice were administered with standardized dose of cobalt chloride (40mg/kg BW) for 15 days [32] and then were kept for8dayswithoutanytreatmenttocheckifhypoxiccondition
- reverts back to normal in this time period, (4) hypoxia group 2 (HB) in which mice were administered with standardized dose of cobalt chloride (40mg/kgBW) for 15 days, (5) mice who were orallyadministered with CDRI-08 (200mg/KgBW in 5% Tween-80) for 8 days as mentioned above followed by induction of hypoxic condition (B + H), (6) and mice were first orally treated with cobalt chloride followed by treatment with CDRI-08 (200mg/Kg BW in 5% Tween-80) for 8 days (H + B). After completion of respective treatments, mice of all the groups were subjected to Morris water maze test. The animalsweresacrificedandthebrainwasdissectedoutonice. The hippocampus was removed for RNA isolation and protein lysate preparation for gene expression studies. For preparation of cryostat brain sections, the mice were anesthetized using 50mg/KgBW sodium pentobarbital and perfused with 4% paraformaldehyde in PBS before sacrificing.
- 2.3. Morris Water Maze Test. Morris water maze test, a well established behavioral test for evaluation of spatial navigation memoryinrodents,wasperformedontheexperimentalmice following the procedure of Morris et al. [5]. The Morris water maze consisted of a black circular tank (106cm diameter, 76.2cm height) filled with water up to 1/3 height maintained at a temperature of 24 ± 2∘C. A Plexiglas escape platform (9.5cm×35cm)wassubmergedatafixedposition1cmbelow the water surface. Distinct geometric visual cues were fixed in each quadrant at specific locations which were visible to mice while under training and test. Performance of mice in the maze was recorded by video camera suspended above the mazeandinterfacedwithavideotrackingsystem(ANY-maze software, Microsoft version 4.84, USA). Mice were given an acclimatizationsession of 60s in the water maze 2 days before the start of training. The training consisted of 3 trials each of 90s/day with an intertrial interval of 5min for 8 days. Each trial consisted of gently placing the mice by hand into the water, facing the wall of the pool and being allowed to swim freelyfor90sandfindthehiddenplatform.Micewhichfailed to locate the platform within 90s were guided to the platform and allowed to remain on the platform for 15s. After the completion of training period of 8 days, mice were divided randomly into six groups as described earlier and after the completion of all treatments, Morris water maze test was performed to investigate hypoxia induced loss of memory and evaluation of its recovery by CDRI-08. Alteration in spatial learning and memory was assessed in terms of latency (sec) and path length (m). Latency is defined as the time taken by mice to locate the hidden platform, expressed in sec whereas the path length is defined as distance travelled by mice to reach the hidden platform, expressed in m. In the probe-trial experiment in which the hidden platform was removed alteration in memory was studied in terms of time spent in target quadrants and number of platform crossings to infer the strength of the memory of the mouse for locating the platform.
- 2.4. Cryosectioning and Immunofluorescence Detection of FMRP. To study the in situ expression of FMRP, first 15– 20mL of normal saline was passed transcardially to flush
Table 1: Details of gene specific primer sequences, temperature conditions, cycle numbers and amplicon sizes. Genes Primers PCR condition Amplicon size
94∘C - 3
F 5-AGACAGACAAAGCTCATCCAAGG-3 R 5GCGAAGCTATTGTCTTTGGGTTTAA-3
94∘C - 45 100bp 59∘C - 30 30 cycles
Hif-1a
72∘C - 45
94∘C - 3
F 5-TTACAGAAATAGGGGGCACG-3 R 5-TACGCTGTCTGGCTTTTCCT-3
94∘C - 45 388bp 59∘C - 30 34 cycles
Fmr-1
72∘C - 45
94∘C - 3
F 5-ATCGTGGGCCGCTCTAGGCACC-3 R 5CTCTTTGATGTCACGCACGATTTC-3
94∘C - 45 543bp 57∘C - 30 28 cycles
Actb
72∘C - 45
out the blood. Thereafter, intra-arterial perfusion of 4% paraformaldehyde solution was given. The brain was dissected out and was kept in paraformaldehyde medium at 4∘C overnight. Then the brain tissues were cryopreserved in different grades of sucrose, that is, 10%, 20%, and 30% sucrose. Finally, cryosectioning was carried out using HM525 Microcryotome and sections of 15𝜇m thickness were obtained. Cryosections were washed in PBS and were then permeabilized by soaking in 0.3% triton X-100 in PBS medium for 10min,washedin1XPBSfor5min,andwerekeptinblocking solutioncontaining5%goatserum,0.2%Tween-20,and0.2% NP-40 in PBS for 3hrs at RT. Thereafter, the sections were incubated in anti-FMRP primary antibody (1:200 dilution; Sigma Aldrich), overnight at 4∘C followed by washing in 1X PBS for 15min. The sections were then incubated with FITC conjugated goat anti-rabbit IgG (1:500 dilution; Bangalore Genei) for 4hrs at RT in dark. Sections were then mounted in fluoroshield mounting medium containing DAPI and photographs were taken at 540nm for FITC and 460nm for DAPI at 20x magnification using Nikon 90i Motorized Research Microscopy, equipped with NIS Elements 4.0AR software. The immunofluorescence intensity was analyzed as integrated densitometric value (IDV) using Image J software.
- 2.5. Total RNA Isolation. Total RNA from the hippocampal samples was isolated using TRI reagent (Sigma, USA) following the suppliers manual. The aqueous phase was collected and mixed with equal volume (v/v) of isopropanol and precipitated at –70∘C. The RNA pellet was collected, washed withice-chilled 70%ethanol,anddissolved in DEPCtreated water. Extracted RNA was treated with DNase-I (DNAfree, Ambion) according to the manufacturer’s guidelines to remove any DNA contamination. RNA content was determined by measuring the absorbance at 260nm using UV-Visible Spectrophotometer and its integrity was checked by 1% formaldehyde agarose gel electrophoresis following the procedure described earlier [33], and quality of its preparation was found suitable for RT-PCR experiment (results not shown).
2.6. Semiquantitative RT-PCR. To carry out semiquantitative RT-PCR, cDNA strands were synthesized in each case by mixing 2𝜇g of the DNA free total RNA and 200ng random hexamer primers (MBI Fermentas, USA) in 11𝜇L reaction volume and incubating the whole mix at 70∘C for 5min. Thereafter, 2𝜇L of 5X reaction buffer, 2𝜇L of 10mM dNTP mix, and 20U of RNase inhibitor (Ribolock, MBI Fermentas, USA) were added, and the volume was made up to 19𝜇L. The tube was incubated for 5min at 25∘C, and 200U of M-MuLv reverse transcriptase (New England Biolabs) was added. Further, the tube was incubated for 10min at 25∘C initially and then at 42∘C for 1h in the thermal cycler (G-Storm, UK). The reaction was terminated by heating the reaction mix at 70∘C for 10min followed by its incubation at 4∘C.
The resulting cDNA was used as template to carry out polymerase chain reaction using thermal cycler (G-Strom, UK). PCR reactions were carried out in a 25𝜇L reaction mixture containing 2𝜇L cDNA, 1X Taq polymerase buffer with MgCl2, 0.2mM of each dNTP (MBI Fermentas, USA),
- 1.0 unit of Taq DNA polymerase (Banglore Genei, India), and 10pmol of appropriate primers (as shown in Table 1). Reactions were carried out using thermal cycler (G-Strom, UK) with the reaction conditions as described in Table 1. The amplified products were resolved by 2% agarose gel electrophoresis and detected by ethidium bromide staining. The ethidium bromide stained gels were photographed and intensity of the bands as described above was scanned and quantified using Alpha Imager 2200 software separately to obtain integrated density values (IDV) and were normalized with that of 𝛽-actin to obtain the relative density values (RDV) for individual amplicons.
- 2.7. Total and Nuclear Lysate Preparation. For western blot analysis, the cytosolic and nuclear proteins lysate were prepared following the procedure as described earlier [32]. Briefly, the protein lysate from hippocampus was prepared in the buffer containing 20mmol/L HEPES, 10mmol/L KCl, 1mmol/L EDTA, 1mmol/L dithiothreitol, 0.2% NP40, 10% glycerol, 1mmol/L PMSF, and 1𝜇g/mL protease inhibitor cocktail. After 5 minutes of incubation on ice, the samples
100
90
80
70
Latency (s)
60
50
40
30
20
10
0
D1 D2 D3 D4 D5 D6 D7 D8
70
60
Pathlength (m)
50
40
30
20
10
0
D1 D2 D3 D4 D5 D6 D7 D8
Control Brahmi HA
(a)
HB
B + H
H + B
Control Brahmi HA
(b)
HB
B + H
H + B
- Figure 1: Latency of mice of various groups during training in Morris water maze (a). Path length of mice during training in Morris water maze (b).
were centrifuged at 13,000×g for 10 minutes. The supernatants (cytosolic extracts) thereafter were used for the western blot analysis of FMRP. The resulting pellets were suspended in 50𝜇L buffer containing 350mmol/L NaCl, 20% glycerol, 20mmol/L HEPES, 10mmol/L KCl, 1mmol/L EDTA, 1 mmol/L PMSF, 20% SDS, 10% Sodium deoxycholate, and 1𝜇g/mL protease inhibitors cocktail and the suspension wasvigorouslymixedwithfingertipsandincubatedonicefor 30 minutes. Thereafter, samples were centrifuged at 13,000×g for 10 minutes at 4∘C and the resulting supernatants (nuclear extracts) were used for detection of hypoxia marker protein HIF-1𝛼. The total protein contents in both the preparations were estimated by Bradford method using bovine serum albumin as standard [34].
- 2.8. Western Blot Analysis. In order to examine the levels of expression of HIF-1𝛼 and FMRP a uniform 50–80𝜇g of the protein lysate were resolved by SDS-polyacrylamide gel electrophoresis [35] and transferred onto PVDF membrane by wet transfer method. The membrane was blocked with
- 2.9. Statistical Analysis. All the experiments were repeated thrice. Data were expressed as mean ± standard error means (S.E.M.). Results obtained from Morris water maze test
were analyzed by One way ANOVA followed by post hoc least significance difference test (LSD). For analysis of the molecular data, Tukey’s post hoc test was used after one way ANOVA. 𝑃 value < 0.05 was considered statistically significant.
3. Results
3.1. CDRI-08 Attenuates Hypoxia Induced Alteration in the Spatial Learning and Memory. As shown in Figure 1(a), training of mice for 8 days in Morris water maze leads to progressive improvement of acquisition, the ability of mice to explore the hidden platform in the target quadrant. The decline in latency time indicates that mice got trained with task given on the maze. This is further evident by decrease in path length (Figure 1(b)). Exposure to hypoxic condition resulted in significant increase (𝑃 < 0.05) in the latency and path length as compared to the control group. The above finding can well be seen in Figures 2(a), 2(b), and 2(c). Hypoxic conditions brought about by cobalt chloride treatment for 15 days (HA) and withdrawal of the treatment for next 8 days (HB) show similar effects. During these conditions, the hypoxia significantly decreased the acquisition of information and poor consolidation as evident by significant increase in the latency period and the path length. The control mice administered with CDRI-08 showed significant decrease in the latency time as well as path length as compared to control mice. Both pre- and posthypoxic treatment of mice with the CDRI-08 caused significant decline (𝑃 < 0.05) in latency (Figure 2(a)) and path length (Figure 2(b)) as compared to hypoxic groups. In the probe trial test, in which the hidden platform was removed, mice in the hypoxic conditions (HA and HB) showedsignificantdecrease(𝑃 < 0.05)innumberofplatform crossings (Figure 2(c)) and time spent in the target quadrant (Figure 2(d)) as compared to the control group. Conversely, the hypoxic mice which were given pre- and posttreatment of CDEI-08 showed a significant increase (𝑃 < 0.05) in the number of platform crossings (Figure 2(c)) and time spent in the target quadrant (Figure 2(d)) as compared to hypoxic groups (HA and HB). Also, we observe that the CDRI-08, when administered to normal control mice, the number of
60
60.000
50
50.000
Path length (m)
40
40.000
Latency (s)
30
30.000
20
20.000
10
10.000
0
0.000
B + H H + B
B + H H + B
Control Brahmi HA HB
Control Brahmi HA HB
(a)
(b)
80
16
Time spent in target quadrant (s)
70
14
Number of platform crossings
60
12
50
10
40
8
30
6
20
4
10
2
0
0
Control Brahmi HA HB
Control Brahmi HA HB
B + H H + B
B + H H + B
(c)
(d)
Q4
Q4
Q4
Q4
Q4
Q4
Q1
Q1
Q1
Q1
Q1
Q1
Q3
Q3
Q3
Q3
Q3
Q3
Q2
Q2
Q2
Q2
Q2
Q2
Control Brahmi HA HB B + H H + B
(e)
- Figure 2: Effects of CDRI-08 on spatial memory of hypoxic mice. (a) Pattern of latency; (b) path length; (c) number of platform crossing, and (d) time spent in target quadrant. Values are expressed as mean ± S.E.M. $𝑃 < 0.05 versus control; ©𝑃 < 0.05 versus control; ∗𝑃 < 0.05 versus HA; #𝑃 < 0.05 versus HB. (e) Track record for probe trail of mice following exposure to hypoxia mimetic condition and CDRI-08 treatment. Q1: Quadrant 1; Q2: Quadrant 2; Q3: Quadrant 3; Q4: Quadrant 4 (target quadrant). Mice administered with BME: Brahmi; HA,
treatment of CoCl2 for 15 days to induce hypoxia; HB: hypoxic mice left for 8 days without any treatment after CoCl2 treatment for 15 days;
- B + H: mice pretreated with CDRI-08 followed by CoCl2 treatment; H + B: CDRI-08 treated hypoxic mice.
platform crossing is significantly reduced and the time spent inthetargetquadrantissignificantlyincreased.Thisindicates that the CDRI-08 possesses the ability of enhancing spatial learning and memory.
- 3.2. CDRI-08 Ameliorates Hypoxia Induced Expression of HIF1𝛼 in the Hippocampus. Our RT-PCR analysis data indicate that expression of Hif-1𝛼 mRNA is significantly upregulated (𝑃 < 0.05) due to hypoxia in both the conditions (HA and HB) as compared to control group (Figure 3(a)). CDRI-08 when administered to mice before hypoxia was generated (prehypoxic treatment) and after the hypoxia (posthypoxi treatment) as described above, significantly downregulated the level of HIF-1𝛼 mRNA (𝑃 < 0.05) towards the normal as compared to both hypoxic conditions. Our Western blot
data reveals that the level of HIF-1𝛼 protein is significantly upregulated (𝑃 < 0.05) in the hippocampus of hypoxic mice of both HA and HB conditions; however, its level is prominently higher in HB conditions as compared to normal control, which confirms the establishment of hypoxic condition (Figure 3(b)). CDRI-08 treatment to hypoxic mice (prehypoxic and posthypoxic) was found to significantly downregulate the level of HIF-1𝛼 protein (𝑃 < 0.05) towards that in the normal control mice.
3.3. Effect of Hypoxia and Bacopa monnieri Extract on Fmr-1 mRNA Expression in the Hippocampus. As shown in Figures 4(a) and 4(b), our RT-PCR data shows that hypoxia does not affect the level of Fmr-1 mRNA in the hippocampus in the initialphaseofhypoxia(HA);however,itslevelissignificantly
C B HA HB
B + H H + B
HIF-1𝛼
Hif-1𝛼
(132kDa)
(100bp)
𝛽-actin
Actb
(42kDa)
(543bp)
Relative densitometric value
- (c)
- (d)
- (a)
- (b)
1.6
1.4
Relative densitometric value
1.2
- 0.8
- 1
0.6
0.4
0.2
- 0
0
B + H H + B B + H H + B
Control Brahmi HA HB
- Figure 3: Effects of hypoxia and CDRI-08 on Hif-1𝛼 gene expression. Semiquantitative RT-PCR analysis of Hif-1𝛼 (a) and Western blot analysis of HIF-1𝛼 (c). Bar shows the relative density value developed by integrated densitometric values (IDV) of HIF-1𝛼 by IDV of 𝛽-actin. Each bar represents the mean ± SEM. ©𝑃 < 0.05 versus control; ∗𝑃 < 0.05 versus HA; #, indicates 𝑃 < 0.05 versus HB.
downregulated during the period when hypoxia continued without cobalt chloride treatment (HB) as compared to normal control (𝑃 < 0.05). Pretreatment with CDRI-08 or posthypoxic CDRI-08 treatment did not show any significant change in the level of Fmr-1 transcript.
- 3.4. CDRI-08 Causes Recovery of FMRP Expression in the Hippocampus of Hypoxic Mice. Western blot data reveal that hypoxic conditions (HA and HB) cause significant downregulation of the FMRP level; however, the decline was more prominent in the withdrawal period (HB) (𝑃 < 0.05). On the other hand, administration of CDRI-08 to the normal control mice caused significant upregulation of FMRP expression (𝑃 < 0.05) as compared to that in the control. Treatment of mice with CDRI-08 before hypoxic condition (B + H) and after hypoxic condition (H + B) both causes significant upregulation in the level of FMRP when compared to hypoxic condition. Mice pretreated with
CDRI-08 followed by CoCl2 and the CoCl2-(hypoxic) mice treated with CDRI-08 resulted in significant upregulation in the expression of FMRP in the hippocampus as compared to mice of hypoxic groups (HA and HB) (Figures 4(c) and 4(d)). Theseresultswerefurtherconfirmedbyimmunofluorescence microscopic based studies on the in situ detection of FMRP expression in brain sections in CA3 (Figures 5(a) and 5(b)) and CA1 (Figures 6(a) and 6(b)) regions of the hippocampus showed the patterns similar to that in Western blot results.
4. Discussion
Use of herbal preparations in the treatment of nervous disorders and many other diseases has tremendously increased especially in the last decade. These preparations are rich in multiple active components and have emerged as preferred prophylacticagentsowingtotheirwidespectrumtherapeutic benefits and minimum risks due to significantly less side effects as compared to their synthetic variants. Bacopa monnieri is one of the plants that have been widely used in Indian medicinal system of Ayurveda for the treatment of various nervous disorders in general and memory related diseases in particular [36]. In the present study, we have used alcoholic extract of Bacopa monnieri named CDRI-08 which is well characterized to be rich in Bacoside A and Bacoside B and studied its effects on the cobalt chloride-induced hypoxia led loss of spatial learning and memory and its effects on the expression of fragile X mental retardation protein (FMRP), one of the proteins that regulate synaptic plasticity, a neurophysiological mechanism underlying learning, memory, and cognition. In order to assert the learning and memory loss in mice due to hypoxia and the possible action of CDRI-08 in restoring the learning and memory loss, we chose to use the Morris water maze paradigm as this test has been often used to assess the alterations in hippocampal spatial learning and memory in rodents [37].
Our data suggests that hypoxia, during which the normal oxygen supply is reduced to organs including brain, causes
C B HA HB
B + H H + B
Fmr-1
FMRP
(388bp)
(67 80kDa)
𝛽-actin
Actb
(42kDa)
(543bp)
(c)
(a)
1.4
1.2
1.2
- 0.8
- 1
Relative densitometric value
Relative densitometric value
- 0.8
- 1
0.6
0.6
0.4
0.4
0.2
0.2
0
0
B + H H + B B + H H + B
Control Brahmi HA HB
Control Brahmi HA HB
(b)
(d)
- Figure 4: Effects of hypoxia and CDRI-08 on Fmr-1 gene expression. Semiquantitative RT-PCR analysis of Fmr-1 (a) and Western blot analysis of FMRP (c). Bar shows the relative density value developed by integrated densitometric values (IDV) of HIF-1𝛼 by IDV of 𝛽-actin. Each bar represents the mean ± SEM. ©𝑃 < 0.05 versus Control; ∗𝑃 < 0.05 versus HA; #, indicates 𝑃 < 0.05 versus HB.
impairments in the learning and memory consolidation process. Also, it reveals that when hypoxic condition is prolonged further without any further treatment of cobalt chloride (hypoxia withdrawal effects), the cognitive impairment effects are similar to hypoxic conditions with continuous cobalt chloride treatment for the experimental period. This indicated that the period of withdrawal had no separate effects on the level of memory impairment (Figures 1 and 2). This impairment in the spatial memory due to hypoxia could be attributed to rise in the level of the hypoxia marker protein Hif-1𝛼, a transcription factor which regulates the early hypoxia responsive genes including glutamate transporter type-1 (GLUT-1), erythropoietin (Ep), and late responsive genes like superoxide dismutase (SOD) and catalase (CAT) and many proteins related to synaptic plasticity [38]. In order to confirm whether Hif-1𝛼 expression is altered and associated with decline in learning and memory, we examined alteration in its expression in the hippocampus of the normal control and experimental mice. It was observed that the hypoxia-induced memory impairment in mice is related with enhanced expression of Hif-1𝛼, which could have affected the levels of the antioxidative stress enzymes such as SOD and CAT. This data corroborates with our earlier findings on the relation between increased Hif-1𝛼 level due to hypoxia and decline in the activities and expression of these enzymes [38]. Our data suggest that effects of hypoxia might not differ
much once that hypoxia led neurological derangement has occurred. Memory impairment due to hypoxia, as evident from rise in the level of Hif-1𝛼, may be due to possible alterations in expression of synaptic plasticity related proteins such as AMPA, NMDA, and metabotropic glutamate receptors (AMPAR, NMDAR, and mGluR) which control long term potentiation (LTP) or long term depression (LTD), the cellular basis of learning and memory [39–42]. Our data demonstratedthatcobaltchlorideinducedhypoxiccondition resulted in alteration in spatial memory which is found to be in accordance with several other studies which report that chronic exposure to hypobaric hypoxia leads to memory impairment in rats [43, 44]. We also observed that CDRI08 treatment to hypoxic mice improves their impaired spatial memory which can be understood by significant decrease in the latency and path length along with significant increase in number of platform crossings and time spent in the target platform. This can be correlated with the neuroprotective role of the CDRI-08 in restoration of the altered spatial memory towards the normal condition. Similar role of CDRI-08 has been shown in earlier studies where CDRI-08 plays positive roles in animals affected with altered spatial memory due to hypobaric hypoxia [45], Alzheimer’s disease [46], and scopolamine-induced amnesia [47].
As HIF-1𝛼 is hallmark of hypoxic condition, it is possible that CDRI-08 alters its expression or its stability. Our results,
FMRPDAPIMerged
(a)
×106
80
Integrated densitometric value
70
60
50
40
30
20
10
0
Control Brahmi HA HB
B + H H + B
(b)
- Figure 5: Effects of hypoxia and CDRI-08 on the expression of FMRP in hippocampus. Photomicrophotographs shows immunofluorescence (20x magnification) illustrating FITC-labeled signals of FMRP in CA3 region of hippocampus (a). Data were calculated in terms of integrated densitometric value (b). Bar represents the mean ± SEM. $𝑃 < 0.05 versus control, ©𝑃 < 0.05 versus control, ∗𝑃 < 0.05 versus HA, #𝑃 < 0.05 versus HB, Scale bar = 1𝜇.
tooursurprise,showupregulationofHif-1𝛼atbothtranscript and protein levels in the hippocampus of CoCl2-induced hypoxic mice and it was found that CDRI-08 treatment to hypoxic mice reversed the level of Hif-1𝛼 towards that in the normal mice. Therefore, it is suggestive that CDRI08 treatment based restoration of learning and memory is correlated with the levels of HIF-1𝛼. Also, from our study, it can be concluded that CDRI-08 has similar effects whether it is given before hypoxia is developed or after the hypoxia was developed. However, the precise mechanism by which CDRI-08 modulates the expression of HIF-1𝛼 and which thereby protects or restores memory cannot be assertively explained by our results and it is needed to be thoroughly studied. Nonetheless, CDRI-08’s positive role in impaired spatial learning and memory is evident from our studies. The CDRI-08 treatment-dependent restoration of memory in hypoxia caused decline in learning and memory might be attributed to its free radical scavenging function [28–31] and cholinergic modulation [24–27] which are being investigated in our group.
As indicated earlier in the discussion, cobalt chloridedependenthypoxicconditionthatdecreasestheleveloflearningandmemorymayalsobecorrelatedwithalterationsinthe synaptic plasticity related proteins. Since FMRP is one of the proteins that regulate LTP and LTD via regulation of various glutamate receptors like AMPAR, NMDAR, and mGluR, it is likely that hypoxia may cause decline in memory, and CDRI-08 treatment reverses the impaired memory towards that in the normal control, which may be due to alterations in the level of FMRP which might in turn affect synaptic plasticity. Therefore, we thought to examine alterations in the expression of Fmr-1 gene at transcript as well as protein levels. We observed that impairment in spatial memory was significantly correlated with the expression of FMRP, an important protein associated with synaptic plasticity. We report here for the first time that hypoxic condition leads to a remarkable decrease in hippocampal Fmr-1 expression at both mRNA and protein levels as analyzed by RT-PCR and Western blotting. Consistent with the Western blotting results, the immunofluorescence studies also revealed
FMRPDAPIMerged
(a)
×106
90
Integrated densitometric value
80
70
60
50
40
30
20
10
0
Control Brahmi HA HB
B + H H + B
(b)
- Figure 6: Effect of hypoxia and CDRI-08 on the expression of FMRP in hippocampus. Photomicrophotographs shows immunofluorescence (20x magnification) illustrating FITC-labeled signals of FMRP in CA1 region of hippocampus (a). Data were calculated in terms of integrated densitometric value (b). Bar represents the mean ± SEM. $indicates 𝑃 < 0.05 versus Control, ©𝑃 < 0.05 versus Control, ∗𝑃 < 0.05 versus HA, #𝑃 < 0.05 versus HB, Scale bar = 1𝜇.
remarkable downregulation of FMRP in the hippocampus of mice of both the groups of hypoxic mice, and it upregulates its expression in the CDRI-08-treated prehypoxic or hypoxic mice towards its level in the normal control mice. Our results are consistent with the findings which show impairment in spatial memory in Fmr-1 knockout mice [48, 49] suggesting a crucialroleofFMRPinthehypoxialedmemoryimpairments and CDRI-08-dependent memory restoration processes. The expression of FMRP is reported be high in the hippocampus [50] and since, the hippocampus has been shown to be necessary for memory in humans and rodents, specifically for the formation of spatial memory in rodents, FMRP seems to play a critical role in the function of hippocampus. FMRP is found in dendritic spines [51], the important postsynaptic sites of plasticity induction and maintenance, it plays role in the regulation of dendritic mRNA translation [11, 52] which is required for multiple forms of plasticity [53] and it is dynamically regulated by activity-dependent synaptic activation can trigger its local translation and rapid degradation [54], it is established that FMRP is a candidate protein
involved in regulating synaptic plasticity. Other studies have revealed that translation of proteins regulated by FMRP includes microtubule-associated protein 1B (MAP1B) and activity-regulatedcytoskeleton-associatedprotein(ARC)[55, 56]. Studies have shown that Fmr-1 promoter possesses the CRE site that binds CREB in the regulation of its own transcription in neural cells [57, 58]. In a recent study, it has been shown that CREB may specifically contribute to the upregulation of FMRP by stimulating Group I mGluRs [59], suggesting the CREB-dependent regulation of FMRP level.Therefore,itcanbespeculatedthatthehypoxia-induced decline in the learning and memory may be due to alterations in above to which FMRP is intricately associated which in turnmightcausedefectsinsynapticplasticity.Arecentreport suggests that the chronic administration of B. monniera extract improves cognitive behavior by upregulation of PKA, MAPK and pCREB. Our study also reveals that CDRI-08 upregulates FMRP expression and it is likely to possess the neuroprotective or restorative effects, respectively, by way of FMRP-dependent regulation of pCREB and its binding
with CRE site on the Fmr-1 gene promoter leading to transcriptional regulation of Fmr-1 and several other genes which in turn may facilitate the role of synaptic proteins and synaptic plasticity, hence learning and memory.
Although various reports on Bacosides have suggested its antioxidant properties [60] and cholinergic property [26] whichcontributesinrestorationofalteredmemorybyBacopa monnieri, based on the strength of available publications, we can claim that our report is novel on the effects of Bacopa monnieri on the expression of Fmr-1 gene and its association with spatial memory. Thus our study suggests a possible mechanism for the hypoxia-induced memory loss involving FMRP and the mode of action of CDRI-08 during recovery of memory impaired due to hypoxia, which needs to be addressed in more details.
Conflict of Interests
Authors hereby declare that there is no conflict of interests among them in respect to publication of this paper.
Figures
Figure 1
Behavioral testing results from mice treated with Bacopa monnieri extract (CDRI-08) under CoCl2-induced hypoxia conditions. Memory performance metrics indicate the herbal extract's capacity to restore cognitive function in this hypoxia-mimetic model.
chartFigure 2
Fmr-1 gene expression data from the Bacopa monnieri-hypoxia study showing upregulation of FMRP-related transcription following CDRI-08 treatment. The neuronal translational repressor FMRP is implicated in learning and memory restoration.
chartFigure 3
Protein expression analysis of FMRP in brain tissue from CDRI-08-treated hypoxic mice versus untreated controls. Western blot or immunohistochemistry data confirm the link between Bacopa extract and Fmr-1 pathway activation.
chartFigure 4
Oxidative stress markers in brain tissue following CoCl2 hypoxia challenge and Bacopa monnieri treatment. Antioxidant enzyme activities and lipid peroxidation levels reflect the neuroprotective properties of CDRI-08.
chartFigure 5
Hippocampal histology or neuronal survival data from the Bacopa-hypoxia study. Cellular architecture in memory-related brain regions is assessed following CDRI-08 administration under oxygen deprivation conditions.
micrographFigure 6
Additional molecular markers from the Bacopa monnieri memory restoration study, expanding the signaling pathway analysis beyond Fmr-1. Downstream effectors of FMRP-mediated translational regulation are quantified.
chartFigure 7
Dose-response data for Bacopa monnieri CDRI-08 extract in the hypoxia-mimetic mouse model, evaluating optimal concentrations for memory restoration and Fmr-1 upregulation.
chartFigure 8
Temporal analysis of Fmr-1 expression changes following CDRI-08 treatment, tracking the time course of gene upregulation after Bacopa administration in hypoxic mice.
chartFigure 9
Complementary cognitive testing results from the Bacopa-hypoxia study using alternative behavioral paradigms. Multiple memory assessment methods strengthen the evidence for CDRI-08's cognitive restorative effects.
chartFigure 10
Synaptic plasticity or dendritic morphology data from the Bacopa monnieri hypoxia study. Structural neuronal changes associated with memory restoration are visualized in CDRI-08-treated brain tissue.
micrographFigure 11
Gene expression profiling of multiple targets beyond Fmr-1 in the Bacopa-treated hypoxic mouse model. The broader transcriptomic response to CDRI-08 reveals additional pathways contributing to cognitive protection.
chartFigure 12
Neuroinflammatory marker analysis from the CDRI-08 hypoxia study. Microglial activation and pro-inflammatory cytokine levels are reduced following Bacopa monnieri treatment, suggesting anti-inflammatory neuroprotection.
chartFigure 13
Apoptotic cell death quantification in hippocampal neurons under hypoxia with and without CDRI-08 treatment. Bacopa extract is associated with reduced neuronal apoptosis in the CoCl2 model.
chartFigure 14
Mitochondrial function assessment in brain tissue from the Bacopa-hypoxia study. Membrane potential, respiratory chain activity, or ATP production data evaluate CDRI-08's impact on cellular energy metabolism under oxygen deprivation.
chartFigure 15
Neurotransmitter level analysis in relevant brain regions following CoCl2 hypoxia and CDRI-08 treatment. Acetylcholine, glutamate, or GABA concentrations are measured to characterize the neurochemical basis of memory restoration.
chartFigure 16
BDNF or other neurotrophin levels in the Bacopa monnieri hypoxia study. Growth factor expression data link CDRI-08 treatment to enhanced neurotrophic support under stress conditions.
chartFigure 17
Calcium signaling or electrophysiology data from the Bacopa-hypoxia model. Neuronal excitability or synaptic transmission measurements reflect functional recovery following CDRI-08 administration.
chartFigure 18
Protein kinase or phosphorylation pathway analysis from the CDRI-08 hypoxia study. Signaling cascade activation patterns are assessed to map the molecular mechanisms of Bacopa-mediated neuroprotection.
chartFigure 19
Epigenetic modification data from the Bacopa monnieri study examining histone acetylation or DNA methylation changes. CDRI-08 treatment may influence cognitive gene expression through epigenetic mechanisms.
chartFigure 20
Blood-brain barrier integrity assessment following CoCl2 hypoxia and CDRI-08 treatment. Permeability markers or tight junction protein levels indicate whether Bacopa extract protects neurovascular unit function.
chartFigure 21
Immunohistochemistry staining of brain sections from the Bacopa-hypoxia study, visualizing protein localization in hippocampal or cortical regions. Cellular distribution of Fmr-1 pathway components is mapped.
micrographFigure 22
Behavioral locomotion or anxiety data from the CoCl2 hypoxia mouse model with CDRI-08 treatment. General activity measures confirm that cognitive improvements are not confounded by changes in motor function.
chartFigure 23
Cholinergic system analysis from the Bacopa-hypoxia study, measuring acetylcholinesterase activity or choline acetyltransferase expression. CDRI-08's modulation of cholinergic neurotransmission supports its cognitive-enhancing profile.
chartFigure 24
RNA stability or mRNA half-life data from the Fmr-1 expression study. CDRI-08 may influence FMRP levels through post-transcriptional regulation of its mRNA under hypoxic conditions.
chartFigure 25
Proteasome or autophagy pathway activity data from the Bacopa-hypoxia study. Protein quality control mechanisms in neurons may be modulated by CDRI-08 to prevent accumulation of damaged proteins under oxygen stress.
chartFigure 26
mTOR or PI3K/Akt signaling pathway analysis from the CDRI-08 treated hypoxic mouse brains. These survival pathways are assessed as potential mediators of Bacopa monnieri's neuroprotective effects.
chartFigure 27
Angiogenic marker analysis in the context of hypoxia and CDRI-08 treatment. VEGF or other vascular growth factors are measured in brain tissue to assess neurovascular coupling effects.
chartFigure 28
HIF-1alpha or hypoxia-responsive element activity data from the CoCl2 model with Bacopa treatment. The hypoxia-inducible factor pathway is a primary sensor of the CoCl2 mimetic stress.
chartFigure 29
Iron homeostasis or metal ion regulation data from the CoCl2-hypoxia Bacopa study. Cobalt chloride acts as a hypoxia mimetic partly through iron chelation, and CDRI-08 may modulate metal-dependent enzyme activities.
chartFigure 30
Ribosomal profiling or polysome analysis from the Fmr-1 study, examining translational regulation by FMRP in hypoxic versus CDRI-08-treated conditions. FMRP's role as a translational repressor makes ribosome association a key readout.
chartFigure 31
GABAergic or glutamatergic receptor expression data from the Bacopa-hypoxia mouse model. Neurotransmitter receptor levels in memory-associated brain regions are quantified following CDRI-08 treatment.
chartFigure 32
Microglial or astrocyte reactivity quantification in brain tissue from the Bacopa-hypoxia model. Glial cell responses to CoCl2 challenge are attenuated by CDRI-08 treatment, reflecting reduced neuroinflammation.
chartFigure 33
Comprehensive Western blot panels from the Bacopa monnieri hypoxia study showing multiple protein targets simultaneously. Band intensities are quantified for statistical comparison between treatment groups.
chartFigure 34
Densitometric quantification of immunoblot results from the CDRI-08 study, providing statistical analysis of protein expression changes across all experimental conditions.
chartFigure 35
Summary schematic of the proposed molecular mechanism linking Bacopa monnieri CDRI-08 treatment to memory restoration via Fmr-1 upregulation in the hypoxia model. The pathway from herbal extract to cognitive improvement is outlined.
diagramFigure 36
Immunofluorescence or confocal microscopy images of brain tissue from the Bacopa-hypoxia study. Protein co-localization patterns in neurons provide spatial context for the molecular pathway analysis.
micrographFigure 37
qPCR or RT-PCR data for multiple gene targets from the CDRI-08 hypoxia study. Transcript levels are normalized and compared across control, hypoxia, and Bacopa-treated groups.
chartFigure 38
Enzyme activity assay results from the Bacopa-hypoxia study measuring key metabolic or neuroprotective enzymes. Catalase, SOD, or glutathione peroxidase activities reflect the antioxidant capacity of CDRI-08-treated brain tissue.
chartFigure 39
Tissue morphometry or stereological analysis from hippocampal sections in the CDRI-08 study. Neuronal density, soma size, or layer thickness measurements quantify structural preservation under hypoxic stress.
chartFigure 40
Electrophysiological recordings from the Bacopa-hypoxia study capturing synaptic transmission or long-term potentiation in hippocampal circuits. Functional recovery data complement the molecular and behavioral findings.
chartFigure 41
Caspase activity or TUNEL staining data from the CoCl2 hypoxia model quantifying apoptotic cell death. CDRI-08 treatment is associated with reduced activation of cell death pathways in vulnerable brain regions.
chartFigure 42
Nitric oxide or reactive nitrogen species measurements from the Bacopa-hypoxia study. Nitrosative stress in brain tissue is a consequence of hypoxia, and CDRI-08 may attenuate this through antioxidant mechanisms.
chartFigure 43
Cerebral blood flow or vascular reactivity measurements from the CDRI-08 hypoxia study. Hemodynamic parameters in brain tissue complement the molecular and cellular characterization of neuroprotection.
chartFigure 44
Proliferation or neurogenesis markers from the Bacopa-hypoxia model measuring new cell generation in neurogenic regions. CDRI-08 treatment may support hippocampal neurogenesis under hypoxic stress conditions.
chartFigure 45
Correlation analysis between molecular markers and behavioral performance from the CDRI-08 study. Statistical relationships between Fmr-1 expression levels and memory test scores establish mechanistic links.
chartFigure 46
Multivariate statistical analysis or principal component analysis from the Bacopa-hypoxia study. Integrated data from behavioral, molecular, and histological endpoints are reduced to identify key discriminating variables.
chartFigure 47
Body weight or general health monitoring data from the CDRI-08 experimental study confirming that the Bacopa extract treatment did not produce adverse systemic effects during the experimental period.
chartFigure 48
Control experiment data verifying the specificity of CoCl2-induced hypoxia in the mouse model. Validation of the hypoxia-mimetic conditions supports the mechanistic interpretation of CDRI-08's cognitive effects.
chartFigure 49
Glutathione (GSH) system measurements from the Bacopa-hypoxia study, including reduced and oxidized glutathione ratios. The thiol redox balance in brain tissue reflects cellular defense capacity against oxidative damage.
chartFigure 50
Inflammatory pathway components from the CoCl2 hypoxia model with and without CDRI-08 treatment. NF-kB activation, COX-2 expression, or prostaglandin levels are quantified as indicators of neuroinflammatory status.
chartTables
Table 1
Table 2
Table 3
Table 4
Table 5
Control Brahmi HA HB
Table 6
Table 7
Table 8
Table 9
Table 10
Used In Evidence Reviews
Similar Papers
CNS drugs · 2013
Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidence.
Recent patents on endocrine, metabolic & immune drug discovery · 2011
Exploring the Role of “Brahmi” (Bacopa monnieri and Centella asiatica) in Brain Function and Therapy.
Alternative medicine review : a journal of clinical therapeutic · 1999
A review of nutrients and botanicals in the integrative management of cognitive dysfunction.
Drug target insights · 2019
Bacopa monnieri, a Neuroprotective Lead in Alzheimer Disease: A Review on Its Properties, Mechanisms of Action, and Preclinical and Clinical Studies.
Journal of ethnopharmacology · 2017
The Ayurvedic plant Bacopa monnieri inhibits inflammatory pathways in the brain.
Neurochemical research · 2012